Copaxone (Co-PAX-ohn, copolymer-1 or "cop-1")
Patients with multiple sclerosis will be asking about Copaxone (Co-PAX-ohn, copolymer-1 or "cop-1"). An FDA committee will review it this month. They'll most probably advise approval for patients with relapsing forms of MS.
Copaxone suppresses the immune response that leads to neurological damage. It reduces relapse rates...and might slow disability.
We'll fill you in on more details when it gets approved.